Quick Answer
Cell Source, Inc. reported Operating Income Loss of -$4.33 million for the year ending 2023.
- Cell Source, Inc. showed a decrease of -3.6% in Operating Income Loss from 2022 to 2023.
- This data is from Cell Source, Inc.'s annual report (Form 10-K), filed with the SEC on June 24, 2024.
- XBRL data for this metric is available from 2017 to 2023 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2017 to 2023), Cell Source, Inc.'s Operating Income Loss has declined by 88.6%.
- Historical annual values: Fiscal year 2023: -$4.33 million | Fiscal year 2022: -$4.18 million | Fiscal year 2021: -$4.02 million | Fiscal year 2020: -$3.64 million | Fiscal year 2019: -$3.81 million | Fiscal year 2018: -$2.01 million | Fiscal year 2017: -$2.29 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: